Nuvation Bio (NUVB) Assets (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Assets of $610.2 million for Q1 2026, up 23.91% year-over-year from $492.5 million in Q1 2025, and up 2.59% quarter-over-quarter from $594.8 million in Q4 2025.
Nuvation Bio (NUVB) Assets (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Assets for 7 consecutive years, with $610.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 23.91% year-over-year to $610.2 million; the TTM figure through Mar 2026 stood at $610.2 million (up 23.91% YoY), while the FY2025 annual figure was $594.8 million, up 10.02% from the prior year.
- Assets advanced to $610.2 million in Q1 2026 per NUVB's latest filing, from $594.8 million in the prior quarter.
- Across five years, Assets topped out at $751.8 million in Q1 2022 and bottomed at $492.5 million in Q1 2025.
- Historically, Assets has averaged $626.3 million across 5 years, with a median of $621.5 million in 2023.
- Annual changes were most pronounced in 2025 — Assets retreated 19.68% — and 2026, when it climbed 23.91%.
- Nuvation Bio's Assets stood at $672.1 million in 2022, then fell by 7.54% to $621.5 million in 2023, then slipped by 13.01% to $540.6 million in 2024, then grew by 10.02% to $594.8 million in 2025, then rose by 2.59% to $610.2 million in 2026.
- Business Quant data shows NUVB's Assets at $610.2 million in Q1 2026, $594.8 million in Q4 2025, and $601.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | 744.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 744.50 Mn |
| Mar 31, 2026 | 610.24 Mn |
| Dec 31, 2025 | 594.82 Mn |
| Sep 30, 2025 | 601.56 Mn |
| Jun 30, 2025 | 647.23 Mn |
| Mar 31, 2025 | 492.49 Mn |
| Dec 31, 2024 | 540.63 Mn |
| Sep 30, 2024 | 571.58 Mn |
| Jun 30, 2024 | 594.80 Mn |
| Mar 31, 2024 | 613.13 Mn |
| Dec 31, 2023 | 621.48 Mn |
| Sep 30, 2023 | 630.87 Mn |
| Jun 30, 2023 | 641.41 Mn |
| Mar 31, 2023 | 657.06 Mn |
| Dec 31, 2022 | 672.14 Mn |
| Sep 30, 2022 | 686.49 Mn |
| Jun 30, 2022 | 719.74 Mn |
| Mar 31, 2022 | 751.81 Mn |
| Dec 31, 2021 | 776.15 Mn |
| Sep 30, 2021 | 797.79 Mn |